Literature DB >> 28190434

Intensive care unit-acquired weakness.

J Horn1, G Hermans2.   

Abstract

When critically ill, a severe weakness of the limbs and respiratory muscles often develops with a prolonged stay in the intensive care unit (ICU), a condition vaguely termed intensive care unit-acquired weakness (ICUAW). Many of these patients have serious nerve and muscle injury. This syndrome is most often seen in surviving critically ill patients with sepsis or extensive inflammatory response which results in increased duration of mechanical ventilation and hospital length of stay. Patients with ICUAW often do not fully recover and the disability will seriously impact on their quality of life. In this chapter we discuss the current knowledge on the pathophysiology and risk factors of ICUAW. Tools to diagnose ICUAW, how to separate ICUAW from other disorders, and which possible treatment strategies can be employed are also described. ICUAW is finally receiving the attention it deserves and the expectation is that it can be better understood and prevented.
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  critical illness; electrophysiology; polyneuromyopathy; weakness

Mesh:

Year:  2017        PMID: 28190434     DOI: 10.1016/B978-0-444-63599-0.00029-6

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  6 in total

1.  Multimodal assessment of intensive care unit-acquired weakness in severe stroke patients.

Authors:  Berin Inan; Can Ebru Bekircan-Kurt; Zeynep Ergul-Ulger; Merve Yilmaz; Zeliha Gunnur Dikmen; Ethem Murat Arsava; Mehmet Akif Topcuoglu; Omur Caglar; Merve Basol; Ergun Karaagaoglu; Sevim Erdem-Ozdamar; Ersin Tan; Cagri Mesut Temucin
Journal:  Acta Neurol Belg       Date:  2022-07-06       Impact factor: 2.471

2.  An unusual case of perforation of the alimentary canal following Bigu: A Taoist fasting technique.

Authors:  Jun Wang; Jun Jin; Xiaofeng Xue; Yan Hao; Dongrong Li; Shan Xu; Fang Huang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

3.  Utility of Plasma GDF-15 for Diagnosis and Prognosis Assessment of ICU-Acquired Weakness in Mechanically Ventilated Patients: Prospective Observational Study.

Authors:  Yongpeng Xie; Suxia Liu; Hui Zheng; Lijuan Cao; Kexi Liu; Xiaomin Li
Journal:  Biomed Res Int       Date:  2020-02-11       Impact factor: 3.411

4.  Identification of the toxic threshold of 3-hydroxybutyrate-sodium supplementation in septic mice.

Authors:  Greet Van den Bergh; Lies Langouche; Ruben Weckx; Chloë Goossens; Sarah Derde; Lies Pauwels; Sarah Vander Perre
Journal:  BMC Pharmacol Toxicol       Date:  2021-09-20       Impact factor: 2.483

5.  Nutrient pattern analysis in critically ill patients using Omics technology (NAChO) - Study protocol for a prospective observational study.

Authors:  Joerg C Schefold; Anna S Messmer; Stefanie Wenger; Lionel Müller; Stephan von Haehling; Wolfram Doehner; Jamie S McPhee; Michaela Fux; Kai M Rösler; Olivier Scheidegger; Radu Olariu; Werner Z'Graggen; Serge Rezzi; Dominik Grathwohl; Tobias Konz; Jukka Takala; Bernard Cuenoud; Stephan M Jakob
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

6.  Changes in muscle ultrasound for the diagnosis of intensive care unit acquired weakness in critically ill patients.

Authors:  Weiqing Zhang; Jun Wu; Qiuying Gu; Yanting Gu; Yujin Zhao; Xiaoying Ge; Xiaojing Sun; Jun Lian; Qian Zeng
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.